-
1 Comment
Ekso Bionics Holdings, Inc is currently in a long term downtrend where the price is trading 17.3% below its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.1.
Ekso Bionics Holdings, Inc's total revenue sank by 39.4% to $2M since the same quarter in the previous year.
Its net income has dropped by 46.1% to $-4M since the same quarter in the previous year.
Finally, its free cash flow fell by 11.9% to $-2M since the same quarter in the previous year.
Based on the above factors, Ekso Bionics Holdings, Inc gets an overall score of 1/5.
Sector | Healthcare |
---|---|
Exchange | NASDAQ |
CurrencyCode | USD |
ISIN | US2826443010 |
Industry | Medical Instruments & Supplies |
PE Ratio | None |
---|---|
Dividend Yield | None |
Beta | 1.43 |
Market Cap | 9M |
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EV, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for EKSO using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025